"Antiphospholipid Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).
- Antiphospholipid Syndrome
- Syndrome, Antiphospholipid
- Hughes Syndrome
- Syndrome, Hughes
- Antiphospholipid Antibody Syndrome
- Antibody Syndrome, Antiphospholipid
- Antiphospholipid Antibody Syndromes
- Syndrome, Antiphospholipid Antibody
- Anti-Phospholipid Antibody Syndrome
- Anti Phospholipid Antibody Syndrome
- Antibody Syndrome, Anti-Phospholipid
- Syndrome, Anti-Phospholipid Antibody
- Anti-Phospholipid Syndrome
- Anti Phospholipid Syndrome
- Syndrome, Anti-Phospholipid
Below are MeSH descriptors whose meaning is more general than "Antiphospholipid Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Antiphospholipid Syndrome".
This graph shows the total number of publications written about "Antiphospholipid Syndrome" by people in this website by year, and whether "Antiphospholipid Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Antiphospholipid Syndrome" by people in Profiles.
Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen. Rheumatology (Oxford). 2019 07 01; 58(7):1259-1267.
Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target. JCI Insight. 2017 09 21; 2(18).
Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes. Arthritis Rheumatol. 2016 08; 68(8):1964-9.
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Am J Obstet Gynecol. 2016 Jan; 214(1):108.e1-108.e14.
Direct immunofluorescence testing in the diagnosis of immunobullous disease, collagen vascular disease, and vascular injury syndromes. Dermatol Clin. 2012 Oct; 30(4):763-98, viii.
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum. 2012 Jul; 64(7):2311-8.
Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis. Semin Thromb Hemost. 2011 Oct; 37(7):802-9.
Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment. Semin Thromb Hemost. 2008 Apr; 34(3):256-66.
Thrombolysis in antiphospholipid syndrome: current hematologic perspectives. Curr Rheumatol Rep. 2008 Jan; 10(1):62-6.
Thrombotic microangiopathic hemolytic anemia in a patient with SLE: diagnostic difficulties. Nat Clin Pract Rheumatol. 2007 Jun; 3(6):357-62.